Burnham’s EU comments are the lead UK story and they matter more than they might look. The prime minister told the BBC that Brexit has caused “more harm than good” and confirmed that rejoining the EU is among the options his government will examine, saying Britain could “go all the way.” That is a significant shift in the public framing from a sitting PM, even if the practical timeline for any such move is years away. Sterling traders and anyone with exposure to UK-EU trade flows should be watching how quickly Brussels responds and whether Burnham’s cabinet holds the same line.

Russia has extended its diesel export ban, originally imposed after Ukrainian drone strikes on refineries. The FT flags this as a potential aggravant to an already tight global supply picture. Separately, the White House is reported to be in crunch talks over the same issue, with Big Oil and senior Republicans clashing over voter sensitivity to fuel prices ahead of the midterms. The two stories are distinct but point in the same direction for energy markets: diesel supply risk is not going away.

AMD has agreed to acquire World Labs, the AI startup, for $8.2 billion, with the deal expected to close before year end. This is AMD’s most aggressive move yet to close the gap with Nvidia on AI hardware and software integration. World Labs was building spatial intelligence models, and folding that capability into AMD’s stack is a meaningful escalation in the competition for AI infrastructure spend.

The flydubai incident is worth noting for geopolitical context rather than aviation risk. A Dubai-to-Tel Aviv flight diverted to Saudi Arabia after an apparent fight between pilots triggered distress signals, including one indicating possible unlawful interference. Israeli jets scrambled briefly. The plane landed safely at Tabuk. The fact that Saudi Arabia received an Israeli-bound aircraft without incident is quietly notable given the state of normalisation talks.

The last US and UK troops have left Iraq as the anti-Islamic State coalition mission formally ends, under a deal agreed two years ago. It is a clean close to that chapter, but it shifts the security calculus in the region and removes a layer of Western military presence at a moment when Iranian influence in Iraq remains substantial.

The Ars Technica report on retatrutide, a triple-hormone obesity drug showing weight loss of up to 25% in trials, is worth flagging for anyone with healthcare or pharma exposure. If those numbers hold through later-stage trials, it would materially outperform existing GLP-1 drugs and reshape the competitive landscape in a sector where a lot of capital is already positioned.

The ONS releases UK GDP figures for Q2 tomorrow morning.

Sources

TechCrunch, BBC News, Al Jazeera, FT, Ars Technica, Guardian, The Economist — 2026-09-30